Taurocholic acid sodium salt, ROTICHROM® CHR, 500 mg, glass packaging

5-Hydroxybenzofurazan, 97%, 5g

(R)-1-(tert-Butoxycarbonyl)-3,3-dimethylazetidine-2-carboxylic acid, 98%, 1g

1-(2-ETHYNYLPHENYL)ETHANONE, 95.0%, 100mg

[1,1'-Biphenyl]-2,5-diol, 95.0%, 100g

2-(2-((4-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

4-Bromo-6-fluoroisoquinolin-1(2H)-one, 95.0%, 1g

2-(4-Bromo-2-formylphenoxy)acetonitrile, 97.0%, 1g

METHYL 2-(TERT-BUTOXYCARBONYL(METHYL)AMINO)PROPANOATE, 95.0%, 250mg

Benzyl 4-Hydroxybenzoate [for Biochemical Research]>98.0%(GC)(T)5g

6-CHLORO-4-OXO-1,4-DIHYDROQUINAZOLINE-2-CARBOXYLIC ACID, 97.0%, 250mg

2-Amino-6-bromoquinoline, 95.0%, 5g

ethyl 5-(4-methoxyphenyl)-1,3-oxazole-2-carboxylate, 95.0%, 500mg